Furthermore, it is reported that metformin therapy mitigates cardiovascular outcomes by improving Sirt6 levels in acute myocardial infarction-prediabetes (AMI-PDM) patients (Sardu et al., 2021). Here, SIRT6 is linked to myocardial infarction.